Back
Immune therapy
TREATMENT RESPONSE AND TOXICITIES IN BREAST CANCER
Mark Harries
COMBINED ANALYSIS OF PDL1 AND TILs IN BREAST CANCER: THE NEW NARRATIVE IN DAILY PRACTICE?
Roberto Salgado
CHARACTERISING IMMUNE RESPONSE
Raza Ali
CHAIRS: Andrew Tutt & Adrienne Morgan